| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9252981 | Hepatology Research | 2005 | 4 Pages |
Abstract
The use of routine pre-OLT tumor grading and of an aggressive HCC treatment during the waiting list, in our experience, resulted in a very low risk of pre OLT tumor progression leading to exclusion and of post OLT HCC recurrence.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Alessandro Vitale, Alberto Brolese, Giacomo Zanus, Marco Bassanello, Umberto Montin, Enrico Gringeri, Francesco D'Amico, Francesco Antonio Ciarleglio, Amedeo Carraro, Gianluca Cappuzzo, Alessio Bridda, Davide Francesco D'Amico, Umberto Cillo,